Capitalbio Technology Co., Ltd.

CapitalBio Technology Co., Ltd. (hereinafter referred to as “ the Company ” ) is an industrial platform under CapitalBio Corporation and National Engineering Research Center for Beijing Biochip Technology. It is also the core enterprise that Tsinghua University arranged in life & health field. Established in August 2012, the Company has set up its production, R & D bases, marketing and operation centers of biochips, instruments and equipment in Beijing, Shanghai, Chongqing, Chengdu, Dongguan, Hong Kong and Santiago, US, with a total office area of more than 150,000 m2 and over 2,000 employees. SARS-CoV-2 Integrated Microfluidic Chip Analysis System,Isothermal Microfluidic Chip Analyzer,Microarray Scanner,Eye Segment Analysis Devices,Automated Biochemistry Analyzer,SARS-CoV-2 Nucleic Acid Detection Kit (Integrated Isothermal Amplification Chip Method),Respiratory Pathogens Nucleic Acid Detection Kit (Isothermal Amplification on Disk Chip),Human Papilloma Virus (HPV) Test Kit (Micro-array Chip Method),CapitalBio Fifteen Deafness Gene Mutations Detection Kit (Microarray), Nine Deafness Mutations Detection Kit for Caucasian Populations(Microarray),Hepatitis B Virus (HBV) Genotyping and Resistance Mutation Site Detection Kit (Microarray Chip Method),Thalassemia Gene Mutations Detection Kit (Microarray),M. Tuberculosis Drug Resistance Gene Real-Time PCR Detection Kit,CapitalBioTM Mycobacteria Identification Array Kit,Test Kit for Three Indexes of Glycolipid